DNA/MVA vaccine: Completed Phase I/II enrollment

GeoVax completed enrollment of 9 HIV-infected patients with suppressed viremia who started anti-retroviral (ART) therapy within 18 months of a negative HIV antibody test in the open-label, U.S. Phase ...